The Andersons, Inc. to Host 2025 Investor Day

TheAndersons, Inc. (Nasdaq: ANDE), announced today that it will host an Investor Day on Tuesday, December 9, 2025, in New York City. https://mma.prnewswire.com/media/74436/THE_ANDERSONS_LOGO.jpg President and Chief Executive Officer Bill Krueger, Executive Vice President and Chief Financial Officer Brian Valentine, and other members of the executive management team will provide a comprehensive overview of the company's […]

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

(NasdaqGM:SABS),(NasdaqGM:SABSW), MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human anti-thymocyte immunoglobulin (hIgG) for delaying the onset and progression of autoimmune type 1 diabetes (T1D), today announced that it will present at

Methode Electronics Reschedules First Quarter Fiscal 2026 Earnings Release and Conference Call

(NYSE:MEI), CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system and power distribution applications, announced today that it has postponed the release of its financial results for the first quarter of fiscal 2026, which had previously been scheduled for September

ThredUp to Participate in Wells Fargo Conference

(NASDAQ:TDUP), OAKLAND, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, announced today that CEO and co-founder James Reinhart and CFO Sean Sobers will participate in the following investor conference: 8th Annual Wells Fargo Consumer ConferenceWednesday, Sept 17, 20259:30

Longeveron(R) Announces Key Leadership Updates

(NASDAQ:LGVN),(NASDAQ:LGVNR), Than Powell, Chief Business Officer and head of business development, appointed Interim CEO Dr. Joshua Hare, co-founder and chief science officer, appointed Executive Chairman of the Board of Directors Wa'el Hashad to step down as CEO and Board member National search to occur for permanent CEO MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) — Longeveron

Remitly Announces Upcoming Investor Webinar and Product Event

(NASDAQ:RELY), SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that its management team will present at the following webinar and product event: Remitly Webinar on Product Innovation/StablecoinsDate: Tuesday, September 9, 2025Time: 11 a.m. Eastern Time / 8 a.m.

XPO Provides North American LTL Operating Data for August 2025

(NYSE:XPO), GREENWICH, Conn., Sept. 03, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for August 2025. LTL tonnage per day decreased 4.7%, as compared with August 2024, attributable to a year-over-year decrease of 3.4% in shipments per day and

Noodles & Company Announces Review of Strategic Alternatives to Maximize Shareholder Value

(NASDAQ:NDLS), BROOMFIELD, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential strategic alternatives, including refinancing of existing indebtedness, refranchising or sale

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced six presentations, including three oral presentations, at the 2025 International HBV Meeting, being held September 8 – 12, 2025

Stitch Fix Announces Date for Fourth Quarter and Full Fiscal Year 2025 Financial Results and Conference Call

(NASDAQ:SFIX), SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its fourth quarter and full fiscal year 2025 ended August 2, 2025 after market close on Wednesday, September 24, 2025. Following this, Stitch Fix will hold a

Scroll to Top